Publikationen von E. Rapp

Vester, D.; Rapp, E.; Genzel, Y.; Gade, D.; Reichl, U.: Dynamics of the proteomes of mammalian cell lines during influenza A virus infection. HuPo 2008, Amsterdam, The Netherlands (2008)

Rapp, E.; Schwarzer, J.; Reichl, U.: Elucidation of the Influenza A Virus Glycosylation-Patterns with Respect to Vaccine-Production Down to the Zeptomolar Range. 3rd Glycan Forum Berlin 2007, Berlin-Dahlem, Germany (2007)

Schwarzer, J.; Rapp, E.; Reichl, U.: Analysis of Influenza Virus Hemagglutinin N-Glycosylation - Influence of Upstream Process Conditions. Vaccine Congress, Amsterdam, The Netherlands (2007)

Schwarzer, J.; Rapp, E.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. Biochemical Engineering XV, Québec City, Canada (2007)

Schwarzer, J.; Rapp, E.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. 20th ESACT Meeting, Dresden, Germany (2007)

Schwarzer, J.; Rapp, E.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. BioPerspectives 2007, Köln, Germany (2007)

Schwarzer, J.; Rapp, E.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. 7th Carbohydrate Bioengineering Meeting (CBM7), Braunschweig, Germany (2007)

Schwarzer, J.; Rapp, E.; Reichl, U.: Analysis of Influenza A Virus Hemagglutinin (HA) Glycosylation by Capillary Gel electrophoresis – Laser induced Fluorescence. MicroScale Bioseparations (MSB), Vancouver BC, Canada (2007)

Vester, D.; Rapp, E.; Genzel, Y.; Gade, D.; Reichl, U.: Proteomic analysis of influenza A virus infected mammalian cells by 2D-DIGE. 20th ESACT Meeting, Dresden, Germany (2007)

Opitz, L.; Wolff, M. W.; Salaklang, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Lectin-affinity purification of cell culture derived human Influenza A viruses. Vaccine Technology 2006, Puerto Vallarta, Mexico (2006)

Opitz, L.; Wolff, M. W.; Salaklang, J.; Rapp, E.; Reichl, U.: Lektin-Affinitätschromatographie zur Aufreinigung humaner Influenza Viren. GVC/DECHEMA-Jahrestagungen 2006, Wiesbaden, Germany (2006)

Opitz, L.; Wolff, M. W.; Salaklang, J.; Rapp, E.; Reichl, U.: Lectin-affinity purification of cell culture derived human Influenza A viruses. ESBES 6 : 6th European Symposium on Biochemical Engineering Science, Salzburg, Austria (2006)

Schwarzer, J.; Rapp, E.; Schmidt, J. K.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. 6th European Symposium on Biochemical Engineering Science (ESBES), Salzburg, Austria (2006)

Schwarzer, J.; Wolff, M. W.; Rapp, E.; Schmidt, J. K.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)

Schwarzer, J.; Wolff, M. W.; Rapp, E.; Schmidt, J. K.; Opitz, L.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. CCE IX (Cell Culture Engineering IX) 2004, Riviera Maya , Cancun, QR, Mexico (2004)

Trbojević-Akmačić, I.; Abdel-Mohsen, M.; Falck, D.; Rapp, E.: Editorial: Immunoglobulin Glycosylation Analysis: State-of-the-Art Methods and Applications in Immunology. Frontiers in Immunology 13, 923393 (2022)

Rapp, E.; Reichl, U.: Preface to Advances in Glycobiotechnology. Advances in Glycobiotechnology, S. i - vi (2021)

Karsten, C. B.; Buettner, F. F. R.; Cajic, S.; Nehlmeier, I.; Roshani, B.; Klippert, A.; Sauermann, U.; Stolte-Leeb, N.; Reichl, U.; Gerardy-Schahn, R. et al.; Rapp, E.; Stahl-Hennig, C.; Pöhlmann, S.: Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. bioRxiv (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Immunoglobulin A Carries Sulfated N glycans Primarily at the Tailpiece Site – An Oxonium-Ion-Guided Approach for Site-Specific N glycan Identification. bioRxiv (2024)

Zuniga-Banuelos, F. J.; Hoffmann, M.; Reichl, U.; Rapp, E.: New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N glycoproteome. bioRxiv (2023)